BCM
Bayesian Capital Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,274
| Closed | -$1.75M | – | 754 |
|
|
2024
Q2 | $1.75M | Buy |
32,274
+1,600
| +5% | +$86.7K | 0.2% | 135 |
|
|
2024
Q1 | $2.15M | Sell |
30,674
-8,000
| -21% | -$561K | 0.21% | 141 |
|
|
2023
Q4 | $3.23M | Buy |
+38,674
| New | +$3.23M | 0.34% | 68 |
|
|
2023
Q2 | – | Sell |
-15,124
| Closed | -$532K | – | 838 |
|
|
2023
Q1 | $532K | Buy |
15,124
+5,924
| +64% | +$208K | 0.07% | 375 |
|
|
2022
Q4 | $422K | Buy |
+9,200
| New | +$422K | 0.06% | 398 |
|
|
2022
Q3 | – | Sell |
-5,900
| Closed | -$232K | – | 755 |
|
|
2022
Q2 | $232K | Buy |
+5,900
| New | +$232K | 0.04% | 573 |
|
|
2017
Q1 | – | Sell |
-13,100
| Closed | -$159K | – | 468 |
|
|
2016
Q4 | $159K | Buy |
+13,100
| New | +$159K | 0.04% | 543 |
|